The Second Life of Methylarginines as Cardiovascular Targets

Endogenous methylarginines were proposed as cardiovascular risk factors more than two decades ago, however, so far, this knowledge has not led to the development of novel therapeutic approaches. The initial studies were primarily focused on the endogenous inhibitors of nitric oxide synthases asymmet...

Descripción completa

Detalles Bibliográficos
Autores principales: Jarzebska, Natalia, Mangoni, Arduino A., Martens-Lobenhoffer, Jens, Bode-Böger, Stefanie M., Rodionov, Roman N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769906/
https://www.ncbi.nlm.nih.gov/pubmed/31533264
http://dx.doi.org/10.3390/ijms20184592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769906/
https://www.ncbi.nlm.nih.gov/pubmed/31533264
http://dx.doi.org/10.3390/ijms20184592

Ejemplares similares